Stock Report Protagonist Therapeutics Inc with In-Depth Stock Analysis

Protagonist Therapeutics Inc XNAS: PTGX

Expensive Rocket

47.47 -0.11 (-0.23%)

67.38% Gain from 52W Low

787.4K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Protagonist Therapeutics Inc is on 02 Jun 2025 for the purpose of Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025 See details

67.38% Gain from 52W Low

Detailed Stock Analysis for Protagonist Therapeutics Inc with Real-time Stock Report